<DOC>
	<DOCNO>NCT01404104</DOCNO>
	<brief_summary>Temsirolimus drug study possibly treat kidney cancer . It work starve cancer nutrient , cut blood supply , hop shrink cancer . This study look experimental use temsirolimus , 12 week prior surgical removal entire kidney portion kidney involve tumor .</brief_summary>
	<brief_title>Neo-adjuvant Temsirolimus Patients With Advanced Renal Cell Carcinoma</brief_title>
	<detailed_description>This study also find whether certain biological factor show patient treatment drug . This able predict disease respond therapy ( biomarkers ) , possibly allow anti-cancer therapy develop future tailor patient 's need .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>At least 18 year old capable give informed consent . Patient radiological evidence RCC consisting : CT scan stage T2 , T3 , T3a , T4 , stage T N1/2 and/or metastatic disease . Patient already nephrectomy . Adequate cardiac function assess electrocardiogram ( ECG ) . Patient kidney biopsy baseline/screening . Patient score 0 1 ECOG . Patient negative HIV , Hepatitis B , Hepatitis C If patient woman childbearing potential , negative pregnancy test . Patient stage T1 disease without metastasis . Patient abnormal laboratory value screen within follow range : Absolute neutrophil count ≤1.5 x 10 ( 9 ) /L ; Platelet count ≤ 100 x 10 ( 9 ) /L Leukocyte count ≤ 3 x 10 ( 9 ) /L ; Hemoglobin ≤ 80 g/L Serum creatinine ≥ 2.0 x upper normal limit ( UNL ) Total bilirubin ≤ 1.5 x UNL ; AST ALT ≤ 3.0 x UNL Fasting serum cholesterol ≤ 9.0 mmol/L Fasting serum triglyceride ≤ 5.0 mmol/L Patients know hypersensitivity Temsirolimus . Other currently active malignancy . Currently take medication know interfere metabolism Temsirolimus . Patients receive anticoagulation warfarin . Patients history pulmonary hypertension interstitial lung disease . Unstable angina judge primary investigator , recent MI last 180 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>